These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1538752)

  • 1. Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer.
    Spies T; Cerundolo V; Colonna M; Cresswell P; Townsend A; DeMars R
    Nature; 1992 Feb; 355(6361):644-6. PubMed ID: 1538752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class II MHC molecules can use the endogenous pathway of antigen presentation.
    Nuchtern JG; Biddison WE; Klausner RD
    Nature; 1990 Jan; 343(6253):74-6. PubMed ID: 1967486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells.
    Zweerink HJ; Gammon MC; Utz U; Sauma SY; Harrer T; Hawkins JC; Johnson RP; Sirotina A; Hermes JD; Walker BD
    J Immunol; 1993 Mar; 150(5):1763-71. PubMed ID: 7679694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs.
    Albert ML; Sauter B; Bhardwaj N
    Nature; 1998 Mar; 392(6671):86-9. PubMed ID: 9510252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigen.
    Milligan GN; Morrison LA; Gorka J; Braciale VL; Braciale TJ
    J Immunol; 1990 Nov; 145(10):3188-93. PubMed ID: 1700000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential recruitment of viral and allo-epitopes into the MHC class I antigen processing pathway of a novel mutant of Ltk- cells. HSV/MHC class I restriction/immune recognition/antigen processing/antigen presentation/influenza virus.
    Lippé R; Kolaitis G; Michaelis C; Tufaro F; Jefferies WA
    J Immunol; 1993 Apr; 150(8 Pt 1):3170-9. PubMed ID: 7682234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nucleoprotein peptide of influenza A virus stimulates assembly of HLA-B27 class I heavy chains and beta 2-microglobulin translated in vitro.
    Kvist S; Hamann U
    Nature; 1990 Nov; 348(6300):446-8. PubMed ID: 2247148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-restricted recognition of viral antigens in HLA transgenic mice.
    Kievits F; Ivanyi P; Krimpenfort P; Berns A; Ploegh HL
    Nature; 1987 Oct 1-7; 329(6138):447-9. PubMed ID: 2821399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of bioactive chimeric MHC class I tetramer by expression and purification of human-murine chimeric MHC heavy chain and beta(2)m as a fusion protein in Escherichia coli.
    Ren D; Wang F; He X; Jiang L; Li D; Ying H; Sun S
    Protein Expr Purif; 2006 Dec; 50(2):171-8. PubMed ID: 17046278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of a naturally occurring HLA class I-restricted viral epitope.
    Falk K; Rötzschke O; Stevanović S; Gnau V; Sparbier K; Jung G; Rammensee HG; Walden P
    Immunology; 1994 Jul; 82(3):337-42. PubMed ID: 7525458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
    Zügel U; Schoel B; Kaufmann SH
    J Immunol; 1994 Nov; 153(9):4070-80. PubMed ID: 7523514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presentation of viral antigen controlled by a gene in the major histocompatibility complex.
    Cerundolo V; Alexander J; Anderson K; Lamb C; Cresswell P; McMichael A; Gotch F; Townsend A
    Nature; 1990 May; 345(6274):449-52. PubMed ID: 2342577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of overlapping class I and class II H-2d-restricted T cell determinants of influenza virus N1 neuraminidase that require infectious virus for presentation.
    Wysocka M; Eisenlohr LC; Otvos L; Horowitz D; Yewdell JW; Bennink JR; Hackett CJ
    Virology; 1994 May; 201(1):86-94. PubMed ID: 7513927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells.
    Malnati MS; Marti M; LaVaute T; Jaraquemada D; Biddison W; DeMars R; Long EO
    Nature; 1992 Jun; 357(6380):702-4. PubMed ID: 1614517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2.
    Gotch F; Rothbard J; Howland K; Townsend A; McMichael A
    Nature; 1987 Apr 30-May 6; 326(6116):881-2. PubMed ID: 2437457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen.
    Pinet V; Malnati MS; Long EO
    J Immunol; 1994 May; 152(10):4852-60. PubMed ID: 8176208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter.
    Spies T; DeMars R
    Nature; 1991 May; 351(6324):323-4. PubMed ID: 2034277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides.
    Wei ML; Cresswell P
    Nature; 1992 Apr; 356(6368):443-6. PubMed ID: 1557127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic evidence for difference between intracellular and extracellular peptides in influenza A matrix peptide-specific CTL recognition.
    Matsui M; Moots RJ; Warburton RJ; Peace-Brewer AL; Tussey LG; Quinn DG; McMichael AJ; Frelinger JA
    J Immunol; 1995 Feb; 154(3):1088-96. PubMed ID: 7822785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species specificity in the interaction of CD8 with the alpha 3 domain of MHC class I molecules.
    Newberg MH; Ridge JP; Vining DR; Salter RD; Engelhard VH
    J Immunol; 1992 Jul; 149(1):136-42. PubMed ID: 1607650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.